In a groundbreaking development, the US Food and Drug Administration (FDA) has granted approval for a revolutionary sickle cell treatment named CASGEVY. Utilizing cutting-edge gene-editing technology CRISPR, this breakthrough therapy modifies DNA in patients’ stem cells, eliminating the production of sickle cells that contribute to health complications. CASGEVY marks a significant stride in the quest […]